Evidence map›Paper›PMID 32359498›Full record

ArticleThe Lancet. Oncology2020

Fulvestrant plus capivasertib for metastatic breast cancer.

Ethan B Ludmir, Zachary R McCaw, Dae Hyun Kim, Lu Tian, Lee-Jen Wei

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. COVID-19 challenges and its therapeutics.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  3. Targeting Akt in cancer for precision therapy.Journal of hematology & oncology · 2021
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Ethan B LudmirThe University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zachary R McCawGoogle, Mountain View, CA, USA.
Dae Hyun KimInstitute for Aging Research, Hebrew SeniorLife, Boston, MA, USA.
Lu TianDepartment of Biomedical Data Science, Stanford University School of Medicine, Palo Alto, CA, USA.
Lee-Jen WeiHarvard T. H. Chan School of Public Health, Boston, MA, USA. Electronic address: wei@hsph.harvard.edu.
Google (United States) · USHarvard University · USHebrew SeniorLife · USStanford University · USThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AromataseFulvestrantAromatase InhibitorsEstrogensHumansNeoplasm Recurrence, LocalAromataseAromatase InhibitorsEstrogensFulvestrant

Identifiers

PMID32359498
OpenAlexW3021530000

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.